Baylor researchers uncovered how physical activity helps improve memory in Alzheimer’s disease
The findings open new possibilities for future treatments to prevent or treat the condition.
Read More
Alzheimer’s Disease
An unexpected potential benefit of blood stem cells
Until now blood stem cell mutations have primarily been associated with promoting disease progression. This is the first time that these two mutations have been shown to influence disease in different ways.
Read More
Alzheimer’s disease affects an organism as a whole
The Alzheimer’s Disease Fly Cell Atlas may lead to a better understanding of the condition and improved treatments.
Read More
A combined computational and experimental approach uncovered promising genetic players in Alzheimer’s disease
This study provides solutions to the pressing need to identify factors that influence Alzheimer’s disease risk or resistance while offering a means explore potential biological markers and therapeutic targets.
Read More
The ethics of telling: Alzheimer’s, diagnosis, and the power of communication
When it comes to Alzheimer’s disease, what we say – and how we say it – matters more than we might think. A new article
Read More
How tau becomes a ‘bad guy’ that contributes to Alzheimer’s disease
The findings suggest a strategy to lower tau levels and explore the potential effects in Alzheimer’s disease and tau-induced dementias.
Read More
Not just a ‘bad guy,’ Tau also plays a ‘good guy’ role protecting our brains
This study opens the door to potential new strategies to slow, reverse and treat neurodegenerative conditions.
Read More
Defective serotonin 2C receptors lead to memory deficits in mice and humans
The findings not only provide new insight into the factors regulating healthy memory but also in conditions associated with memory loss, like Alzheimer’s disease.
Read More
Fungal infection in the brain produces changes like those seen in Alzheimer’s disease
This work potentially contributes an important new piece of the puzzle regarding the development of Alzheimer’s disease.
Read More
New Alzheimer’s disease drug shown to slow disease
The recent approval of Leqembi (lecanemab-irmb) by the U.S. Food and Drug Administration as a treatment for Alzheimer’s disease (AD) marks the first amyloid beta-directed
Read More